论文部分内容阅读
Objectives To evaluate the impact of biodegradable polymer drug-eluting stent (BP-DES) on the frequency of stent thrombosis (ST), target lesion revascularization (TLR), myocardial infarction (MI), and all-cause death in randomised controlled trials comparing the BP-DES with durable polymer drug-eluting stents (DP-DES).